Product Program year 2020 Source: CMS Open Payments

BioPharma Sol - Research Devel

Biological BioPharma Solutions

Open in the dashboard

General payments

$61,813

21 payments

Research payments

$2,480,615

15 payments

Through program year 2020, $61,813 in general payments and $2,480,615 in research payments were reported against BioPharma Sol - Research Devel (BioPharma Solutions).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 Research $1,268,298 10
2019 General $61,813 21
2019 Research $1,212,316 5

Breakdown

Who paid General payments · program year 2019
  1. Baxter Healthcare $61,813 21 payments
Top recipients General payments · program year 2019
  1. Northshore University Healthsystem Teaching hospital · IL $57,703 93% · 7 payments
  2. Kenneth Hoffman Hematology & Oncology · Teaneck, NJ $400 <1% · 1 payment
  3. Thai Ho Hematology & Oncology · Scottsdale, AZ $400 <1% · 1 payment
  4. Dean Gesme Medical Oncology · Minneapolis, MN $400 <1% · 1 payment
  5. Tony Tsai Anesthesiology · Renton, WA $375 <1% · 2 payments

The top 5 of 14 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $1,150 28% · 3 practitioners
  2. Anesthesiology $725 18% · 2 practitioners
  3. Medical Oncology Internal Medicine $400 10% · 1 practitioner
  4. Hospitalist $335 8% · 2 practitioners
  5. Nephrology Internal Medicine $300 7% · 1 practitioner

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Illinois $57,703 93% · 1 recipient
  2. Minnesota $750 1% · 2 recipients
  3. Pennsylvania $600 <1% · 2 recipients
  4. Arizona $400 <1% · 1 recipient
  5. New Jersey $400 <1% · 1 recipient

The top 5 of 12 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

21 general · 15 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record